Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • c-Myc tag Peptide: Precision Reagent for Immunoassays & C...

    2026-02-25

    c-Myc tag Peptide: Precision Reagent for Immunoassays & Cancer Biology

    Executive Summary: The c-Myc tag Peptide (SKU: A6003, APExBIO) is a synthetic decapeptide matching amino acids 410–419 of the human c-Myc protein, enabling precise displacement of c-Myc-tagged fusion proteins in immunoassays (APExBIO product page). This reagent robustly inhibits anti-c-Myc antibody binding, enhancing immunoassay specificity and reproducibility (EpitopePeptide article). c-Myc is a master transcription factor regulating cell proliferation, apoptosis, and oncogenesis (Wu et al., 2021). The peptide is highly soluble in DMSO (≥60.17 mg/mL) and water (≥15.7 mg/mL with ultrasonication), but insoluble in ethanol, and must be stored desiccated at –20°C for stability. Its deployment in research is strictly limited to non-clinical applications.

    Biological Rationale

    The c-Myc tag Peptide is engineered to correspond exactly to the C-terminal decapeptide (EQKLISEEDL) of human c-Myc. This epitope is widely used to tag recombinant proteins, facilitating their detection, purification, and quantification in cell and molecular biology workflows (FlagPeptide article). The c-Myc protein itself is a proto-oncogene transcription factor. It regulates genes controlling cell proliferation, cell cycle progression, apoptosis, and stem cell self-renewal (Wu et al., 2021). Overexpression or dysregulation of c-Myc is implicated in numerous human cancers, including lymphomas, breast, and colorectal cancers. The ability to probe c-Myc biology and protein interactions with high specificity is fundamental for cancer research and drug discovery (3xFLAG article).

    Mechanism of Action of c-Myc tag Peptide

    The c-Myc tag Peptide acts by competitively binding to anti-c-Myc antibodies. In immunoprecipitation or immunoaffinity chromatography, it can displace c-Myc-tagged proteins from antibody-bound matrices by saturating the antibody's paratope (c-Myc Peptide article). This mechanism enables specific elution of tagged fusion proteins without denaturation, preserving protein activity and structure. The peptide does not alter endogenous c-Myc function or cellular transcriptional activity, as it typically does not enter live cells in standard assay formats. Its specificity is derived from sequence identity to the human c-Myc 410–419 region, ensuring minimal cross-reactivity with other epitopes. This property allows researchers to achieve high selectivity in immunoassays and related applications (FlagPeptide article).

    Evidence & Benchmarks

    • c-Myc tag Peptide (EQKLISEEDL) specifically inhibits anti-c-Myc antibody binding at concentrations ≥1 μg/mL in standard immunoassay buffers (product documentation).
    • Displacement efficiency of c-Myc-tagged proteins from immobilized antibodies exceeds 90% in optimized elution protocols (EpitopePeptide article).
    • Solubility is ≥60.17 mg/mL in DMSO and ≥15.7 mg/mL in water with ultrasonication at 20°C; the peptide is insoluble in ethanol (APExBIO).
    • c-Myc regulates >15% of human genes involved in cell proliferation and apoptosis through transcription factor activity (Wu et al., 2021).
    • The c-Myc tag sequence does not affect the function of most fusion partners in biochemical assays (His6-Tag article).

    Applications, Limits & Misconceptions

    The c-Myc tag Peptide is validated for use in competitive immunoassays, immunoprecipitation, and affinity purification. It provides a non-denaturing elution strategy for c-Myc-tagged fusion proteins, preserving protein activity for downstream analyses. Researchers in cancer biology leverage the peptide to dissect c-Myc-mediated transcriptional regulation and protein–protein interactions. Its use is documented in mechanistic studies involving cell proliferation, apoptosis, and proto-oncogene amplification (3xFLAG article; this article examines direct comparison benchmarks with 3xFLAG and His6 tags, clarifying performance in competitive elution conditions).

    For a broader discussion on the strategic value of c-Myc tag Peptide in translational cancer research, see Harnessing the Power of c-Myc Tag Peptide, which this article updates with new solubility and workflow integration parameters.

    Common Pitfalls or Misconceptions

    • The c-Myc tag Peptide is not suitable for diagnostic or therapeutic applications; it is strictly for research use (APExBIO).
    • It does not enter live cells under standard conditions and cannot modulate endogenous c-Myc transcriptional activity in intact systems.
    • Peptide solutions stored long-term (>1 week) at 4°C are prone to degradation; aliquot and store desiccated at –20°C for stability.
    • It is not effective in ethanol-based buffers due to insolubility; use DMSO or water (with ultrasonication) for dissolution.
    • Over-saturation (>10x excess) in immunoassays can cause non-specific effects or antibody precipitation.

    Workflow Integration & Parameters

    For optimal use, dissolve the c-Myc tag Peptide in DMSO to a stock concentration of ≥60.17 mg/mL, or in water (≥15.7 mg/mL) with ultrasonic treatment. Aliquot and store at –20°C, desiccated. In immunoprecipitation protocols, add the peptide at a final concentration of 1–5 μg/mL to elute c-Myc-tagged proteins from antibody-conjugated matrices. Avoid using ethanol as a solvent. Routine workflows benefit from the reproducibility and specificity provided by the A6003 reagent (His6-Tag article; this article details updated storage and solubility data not covered previously).

    For a comprehensive overview of practical troubleshooting in cell-based assays, refer to Optimizing Cell Assays with c-Myc tag Peptide, while the present article provides a focused update on mechanistic rationale and quantitative benchmarks.

    Conclusion & Outlook

    The c-Myc tag Peptide (APExBIO, SKU: A6003) is a robust, validated reagent for displacing c-Myc-tagged fusion proteins, enabling high-specificity immunoassays and facilitating research into oncogenic transcription factors. Its well-characterized solubility and storage parameters make it a reliable choice for molecular and cancer biology workflows. As new research elucidates c-Myc’s role in gene amplification and cellular regulation, precise tools like the c-Myc tag Peptide remain essential for advancing mechanistic and translational studies (Wu et al., 2021).

    For product details or ordering information, visit the c-Myc tag Peptide product page.